Lifecore Biomedical, Inc.

LFCRNASDAQHealthcare● Active

$5.57

$-0.06(-1.07%)

Market Cap$208927397

P/E Ratio—

52W High$8.98

52W Low$3.63

Avg Volume347K

Open$5.64

Beta1.07

Net Income Financials Revenue

Lifecore Biomedical, Inc. (LFCR) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

LFCR · net income · updated Jun 9, 2026

Core profitability metrics

LFCR · net income · margin · TTM · CAGR

Net income was −$38.7M for FY2025 (fiscal year ending 2025-05-25), down 422.3% year-over-year. Net profit margin was -30.0%. Based on available data, Lifecore Biomedical, Inc. has been profitable since at least 2011.

FY2025 Net Income−$38.7M▼ -422.3% YoY

Trailing 12M (TTM)−$34.1Mtrailing 4 quarters sum

Net Profit Margin-30.0%−$38.7M ÷ $128.9M

YoY Change-422.3%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · LFCR net income history · LFCR profit margin

Annual net income data

LFCR · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$38.7M▼ 422.3%-30.0%$128.9M

FY2024$12.0M▲ +112.1%9.4%$128.3M

FY2023Loss−$99.6M▲ +14.7%-96.4%$103.3M

FY2022Loss−$116.7M▼ 261.4%-104.9%$111.3M

FY2021Loss−$32.3M▲ +15.4%-32.0%$100.9M

Net income vs peers (Healthcare)

LFCR vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Lifecore Biomedical, Inc.YOU

LFCR

−$38.7M-422.3%-30.0%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Lifecore Biomedical, Inc. (LFCR) reported net income of −$38.7M for FY2025 (fiscal year ending 2025-05-25), down 422.3% year-over-year. The net profit margin was -30.0% — meaning the company kept $-0.30 of every dollar of revenue as profit.

Based on available data, Lifecore Biomedical, Inc. has been profitable since at least 2011. Net income reached a peak of $24.8M in FY2018. Data available for 15 fiscal years.

Lifecore Biomedical, Inc.'s net profit margin was -30.0% for FY2025, based on the latest annual results.

Investors sometimes search for "Lifecore Biomedical, Inc. net worth" — the company's market capitalization is a separate figure from LFCR net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

LFCR net income · 4 questions

Lifecore Biomedical, Inc. is not currently profitable on an annual basis. The company reported a net loss of $38.7M for FY2025.

is LFCR profitabledoes LFCR make a profitLFCR profitabilityLFCR profitable company

▸ Source: FMP /income-statement · GAAP · Lifecore Biomedical, Inc. · Lifecore Biomedical, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026